Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment

Carlotta Perucca Orfei, Giuseppe Talò, Marco Viganò, Sara Perteghella, Gaia Lugano, Francesca Fabro Fontana, Enrico Ragni, Alessandra Colombini, Paola De Luca, Matteo Moretti, Maria Luisa Torre, Laura de Girolamo

Research output: Contribution to journalArticle

Abstract

In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 µL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine.

Original languageEnglish
JournalPharmaceutics
Volume10
Issue number4
DOIs
Publication statusPublished - Oct 24 2018

Fingerprint

Fibroins
Silk
Mesenchymal Stromal Cells
Bioreactors
Cell Size
Cell Adhesion
Suspensions
Stem Cells
Regenerative Medicine
Bone Marrow Cells
Injections
alginic acid

Cite this

Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery : Optimization of Cell Seeding by the Design of Experiment. / Perucca Orfei, Carlotta; Talò, Giuseppe; Viganò, Marco; Perteghella, Sara; Lugano, Gaia; Fabro Fontana, Francesca; Ragni, Enrico; Colombini, Alessandra; De Luca, Paola; Moretti, Matteo; Torre, Maria Luisa; de Girolamo, Laura.

In: Pharmaceutics, Vol. 10, No. 4, 24.10.2018.

Research output: Contribution to journalArticle

Perucca Orfei, Carlotta ; Talò, Giuseppe ; Viganò, Marco ; Perteghella, Sara ; Lugano, Gaia ; Fabro Fontana, Francesca ; Ragni, Enrico ; Colombini, Alessandra ; De Luca, Paola ; Moretti, Matteo ; Torre, Maria Luisa ; de Girolamo, Laura. / Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery : Optimization of Cell Seeding by the Design of Experiment. In: Pharmaceutics. 2018 ; Vol. 10, No. 4.
@article{0d370f404424485aa47e0ea0e98c30d8,
title = "Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery: Optimization of Cell Seeding by the Design of Experiment",
abstract = "In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 µL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine.",
author = "{Perucca Orfei}, Carlotta and Giuseppe Tal{\`o} and Marco Vigan{\`o} and Sara Perteghella and Gaia Lugano and {Fabro Fontana}, Francesca and Enrico Ragni and Alessandra Colombini and {De Luca}, Paola and Matteo Moretti and Torre, {Maria Luisa} and {de Girolamo}, Laura",
year = "2018",
month = "10",
day = "24",
doi = "10.3390/pharmaceutics10040200",
language = "English",
volume = "10",
journal = "Pharmaceutics",
issn = "1999-4923",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

TY - JOUR

T1 - Silk/Fibroin Microcarriers for Mesenchymal Stem Cell Delivery

T2 - Optimization of Cell Seeding by the Design of Experiment

AU - Perucca Orfei, Carlotta

AU - Talò, Giuseppe

AU - Viganò, Marco

AU - Perteghella, Sara

AU - Lugano, Gaia

AU - Fabro Fontana, Francesca

AU - Ragni, Enrico

AU - Colombini, Alessandra

AU - De Luca, Paola

AU - Moretti, Matteo

AU - Torre, Maria Luisa

AU - de Girolamo, Laura

PY - 2018/10/24

Y1 - 2018/10/24

N2 - In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 µL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine.

AB - In this methodological paper, lyophilized fibroin-coated alginate microcarriers (LFAMs) proposed as mesenchymal stem cells (MSCs) delivery systems and optimal MSCs seeding conditions for cell adhesion rate and cell arrangement, was defined by a Design of Experiment (DoE) approach. Cells were co-incubated with microcarriers in a bioreactor for different time intervals and conditions: variable stirring speed, dynamic culture intermittent or continuous, and different volumes of cells-LFAMs loaded in the bioreactor. Intermittent dynamic culture resulted as the most determinant parameter; the volume of LFAMs/cells suspension and the speed used for the dynamic culture contributed as well, whereas time was a less influencing parameter. The optimized seeding conditions were: 98 min of incubation time, 12.3 RPM of speed, and 401.5 µL volume of cells-LFAMs suspension cultured with the intermittent dynamic condition. This DoE predicted protocol was then validated on both human Adipose-derived Stem Cells (hASCs) and human Bone Marrow Stem Cells (hBMSCs), revealing a good cell adhesion rate on the surface of the carriers. In conclusion, microcarriers can be used as cell delivery systems at the target site (by injection or arthroscopic technique), to maintain MSCs and their activity at the injured site for regenerative medicine.

U2 - 10.3390/pharmaceutics10040200

DO - 10.3390/pharmaceutics10040200

M3 - Article

C2 - 30352986

VL - 10

JO - Pharmaceutics

JF - Pharmaceutics

SN - 1999-4923

IS - 4

ER -